ROLES OF PLASMINOGEN ACTIVATORS UPON BRAIN INJURY
纤溶酶原激活剂对脑损伤的作用
基本信息
- 批准号:10671332
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Urokinase type plasminogen activator (uPA) involves tissue fibrinolysis that is related to the healing process, development, and tumor invasion. Plasminogen inhibitor-1 (PAI-1) inhibits the protelytic activity of uPA and may enhance the brain vasculature after brain injury. We studied brain edema and changes in the vasculature after a brain stab wound in uPA-deficient, uPA receptor-deficient, and PAI-1-deficient mice, and control mice. Compared to control mice, the extravasation of immunoglobulin was significantly greater in PAI 1 deficient mice at 3 days after the lesion was placed, less pronounced in uPA-deficient mice and similar to the controls in uPA receptor-deficient mice. Von Willebrand factor-positive vascular structures increased in number 8 days after lesioning in PAI-1 deficient mice. Furthermore, irregular and proliferative collagen Type IV-positive microvasculatures were observed in all PAI-1-deficient mice and in 20% of control mice 8 days after lesion placement. Those findings are indicative of increased angiogenesis. Our study clearly shows that uPA contributes to the development of secondary brain damage due to a breakdown of microvascular extracellular matrix protein, and that uPA plays a role without binding to its receptor in the acute stage. PAI-1 inhibits traumatic brain edema. On the other hand, plasminogen activator facilitates angiogenesis necessary for healing after brain injury.
尿激酶型纤溶酶原激活物(uPA)参与组织纤维蛋白溶解,其与愈合过程、发展和肿瘤侵袭有关。纤溶酶原抑制剂-1(派-1)可抑制uPA的蛋白水解活性,并可增强脑损伤后的脑血管。我们研究了uPA缺陷型、uPA受体缺陷型和派-1缺陷型小鼠以及对照小鼠脑刺伤后的脑水肿和血管变化。与对照组小鼠相比,派1缺陷型小鼠的免疫球蛋白外渗在损伤后3天显著更大,uPA缺陷型小鼠不太明显,而uPA受体缺陷型小鼠与对照组相似。血管性血友病因子阳性血管结构的数量增加8天后,在派-1缺陷型小鼠病变。此外,在所有派-1缺陷小鼠和20%的对照小鼠中观察到病变放置后8天的不规则和增殖的IV型胶原阳性微血管。这些发现表明血管生成增加。我们的研究清楚地表明,由于微血管细胞外基质蛋白的分解,uPA有助于继发性脑损伤的发展,并且uPA在急性期发挥作用而不与其受体结合。派-1抑制创伤性脑水肿。另一方面,纤溶酶原激活剂促进脑损伤后愈合所必需的血管生成。
项目成果
期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kawabata A: "Increased vascular permeability by a specific agonist of protease- activated receptor-2 in rat hindpaw." Br J Pharmacol. 125. 419-422 (1998)
Kawabata A:“通过蛋白酶激活受体 2 的特定激动剂增加大鼠后爪的血管通透性。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kataoka K: "Nigral degeneration following Strlato-pallidul"Neuroscience Letters. 266. 220-222 (1999)
Kataoka K:“Strlato-pallidul 后的黑质变性”神经科学快报。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
片岡 和夫: "能損傷後血管新生におけるPAI-1についての検討"神経外傷. 21. 63-66 (1998)
Kazuo Kataoka:“脑损伤后血管生成中 PAI-1 的研究”《神经创伤》21. 63-66 (1998)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kataoka K: "Structural fragility and inflammatory"Stroke. 30. 1396-1401 (1999)
Kataoka K:“结构脆弱和炎症”中风。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kataoka K, Asai T, Ueshima S, Matsuo O, Taneda M: "A study of angiogenesis after neuronal trauma in relation to plasminogen activator inhibitor-1 (Jpn)"Neurotraumatology. 21. 63-66 (1998)
Kataoka K、Asai T、Ueshima S、Matsuo O、Taneda M:“神经元创伤后血管生成与纤溶酶原激活剂抑制剂 1 相关的研究(日本)”神经创伤学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATAOKA Kazuo其他文献
KATAOKA Kazuo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATAOKA Kazuo', 18)}}的其他基金
A study of subarachnoid hemorrhage and de novo aneurysm
蛛网膜下腔出血与新生动脉瘤的研究
- 批准号:
20591697 - 财政年份:2008
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of Protease-Activated Receptor on Brain Injury.
蛋白酶激活受体在脑损伤中的作用。
- 批准号:
14571346 - 财政年份:2002
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A trial of neurofunctional recovery after brain damage by neurotrophic factor and neural transpolant.
通过神经营养因子和神经移植进行脑损伤后神经功能恢复的试验。
- 批准号:
05671193 - 财政年份:1993
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Disturbance of cholinergic pathway after cerebral hemorrhage and its therapeutic strtategy
脑出血后胆碱能通路紊乱及其治疗策略
- 批准号:
02670641 - 财政年份:1990
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Research Grant
Development of a humanised delivery system for interleukin 2 to treat traumatic brain injury
开发白细胞介素2人源化递送系统来治疗创伤性脑损伤
- 批准号:
MR/X029166/1 - 财政年份:2024
- 资助金额:
$ 1.92万 - 项目类别:
Research Grant
Blood biomarkers to detect brain injury due to intimate partner violence
血液生物标志物可检测亲密伴侣暴力造成的脑损伤
- 批准号:
486950 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Operating Grants
Targeting Ryanodine Receptor 2 for Treating Neonatal Hypoxic-ischemic Brain Injury (HIBI)
靶向 Ryanodine 受体 2 治疗新生儿缺氧缺血性脑损伤 (HIBI)
- 批准号:
488816 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Operating Grants
Who is Caring for the Caregiver? Understanding Quality of Life and Mental Health Outcomes in Caregivers of Persons with Brain Injury
谁在照顾看护者?
- 批准号:
492369 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Operating Grants
A PROGRESS-Driven Approach to Cognitive Outcomes after Traumatic Brain Injury: Advancing Equity, Diversity, and Inclusion through Knowledge Synthesis and Mobilization
创伤性脑损伤后认知结果的进步驱动方法:通过知识合成和动员促进公平、多样性和包容性
- 批准号:
492338 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Operating Grants
Advancing equity in traumatic brain injury care: A stakeholder-informed meeting on screening for traumatic brain injury in underserved populations
促进创伤性脑损伤护理的公平性:关于在服务不足的人群中筛查创伤性脑损伤的利益相关者知情会议
- 批准号:
487815 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Miscellaneous Programs
Traumatic Brain Injury Anti-Seizure Prophylaxis in the Medicare Program
医疗保险计划中的创伤性脑损伤抗癫痫预防
- 批准号:
10715238 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Monocyte-Derived Microglia in Development and after Neonatal Brain Injury
发育中和新生儿脑损伤后的单核细胞衍生的小胶质细胞
- 批准号:
10593385 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Fecal Microbiota Transfer Attenuates Aged Gut Dysbiosis and Functional Deficits after Traumatic Brain Injury
粪便微生物群转移可减轻老年肠道菌群失调和脑外伤后的功能缺陷
- 批准号:
10573109 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别: